首页> 外国专利> ANTITUMOR QUINOXALINE DERIVATIVES HAVING INHIBITORY ACTIVITY AGAINST HISTONE DEACETYLASE AND PREPARATION METHOD THEREOF

ANTITUMOR QUINOXALINE DERIVATIVES HAVING INHIBITORY ACTIVITY AGAINST HISTONE DEACETYLASE AND PREPARATION METHOD THEREOF

机译:具有组氨酸去乙酰化的抑制活性的抗喹喔啉衍生物及其制备方法

摘要

PURPOSE: Quinoxaline derivatives and a preparation method thereof are provided, which derivatives have inhibitory activity against histone deacetylase, which removes an acetyl group from the lysine tail in the N-terminal of histone, by selectively inducing the terminal differentiation of the tumor cells, and thus by inhibiting the growth of tumor cells. CONSTITUTION: The quinoxaline derivatives represented by formula (1) are provided, wherein R1 is aryl, heteroaryl or C3-C8 cycloalkyl which is optionally substituted by one or more substituents selected from hydroxy, halogen, alkyloxy, alkyl, amino, alkylamino, carboxyl, nitro, amide and sulfone in which the heteroaryl contains one or more elements selected from nitrogen, sulfur and oxygen in a ring; R2 is hydrogen or arylalkyl; A is O, S, CH2, sulfone(SO2), sulfoxide(SO), CONH, NHCO, NX or NXSO2 in which X is hydrogen, C1-5 alkyl or independently the same as R1; and n is 0, 1, 2 or 3. The method for preparing a compound of formula (2) comprises the steps of: (a) acylation of 2-bromo arylalkyl carboxylic acid of formula (6) with 3,4-diamino benzoic ester of formula (7) in an aprotic solvent to prepare a compound of formula (8); (b) cyclization of the compounds of formula (8) in the presence of inorganic salts to prepare quinoxaline ester of formula (9); (c) treating the quinoxaline ester of formula (9) with hydroxide salts to prepare an organic acid of formula (10); and (d) acylation of the organic acid of formula (10) with the protected hydroxyl amine and hydrogenating the reaction product in the presence of palladium, wherein Y is O, S, CH2, SO2, SO or NX.
机译:目的:提供喹喔啉衍生物及其制备方法,该衍生物对组蛋白脱乙酰基酶具有抑制活性,该组蛋白脱乙酰基酶通过选择性地诱导肿瘤细胞的末端分化,从组蛋白的N端赖氨酸尾部去除乙酰基,以及因此通过抑制肿瘤细胞的生长。组成:提供了由式(1)表示的喹喔啉衍生物,其中R1为芳基,杂芳基或C3-C8环烷基,其任选地被一个或多个选自以下的取代基取代:羟基,卤素,烷氧基,烷基,氨基,烷基氨基,羧基,硝基,酰胺和砜,其中杂芳基在环中包含一种或多种选自氮,硫和氧的元素; R 2是氢或芳基烷基; A为O,S,CH 2,砜(SO 2),亚砜(SO),CONH,NHCO,NX或NXSO 2,其中X为氢,C 1-5烷基或独立地与R 1相同; n为0、1、2或3。制备式(2)化合物的方法包括以下步骤:(a)将式(6)的2-溴芳基烷基羧酸与3,4-二氨基苯甲酸酯化在非质子溶剂中的式(7)的酯,以制备式(8)的化合物; (b)在无机盐存在下环化式(8)化合物,制备式(9)喹喔啉酯; (c)用氢氧化盐处理式(9)的喹喔啉酯,以制备式(10)的有机酸; (d)用被保护的羟胺酰化式(10)的有机酸,并在钯存在下氢化反应产物,其中Y是O,S,CH 2,SO 2,SO或NX。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号